← Eichor
Study identifier: NCT06766006 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ECMO LEft Ventricle UNloading Strategy

Condition: Shock, Cardiogenic · Cardiac Arrest · Extracorporeal Membrane Oxygenation Complication  ·  Sponsor: Maastricht University Medical Center

PhaseN/A
Planned participants500
Who can joinAll sexes, 1 Day to 80 Years
Healthy volunteersNo

About this study

The present study is an International multicentric prospective observational cohort study. This will be an international research campaign to prospectively collect and analyze clinical data of all VA ECLS patients admitted to participating ICUs with a focus on LV venting modalities. The aims of the study are: * To investigate the meaning of LV overload during veno-arterial (VA) extracorporeal life support; * To extensively describe the left ventricular (LV) unloading strategy during VA extracorporeal life support in a large prospective international cohort. * To compare different strategies to unload the left ventricular in terms of efficacy and outcomes;

This description comes directly from the study's public registry record.

Talk to the study team

Paolo Meani, MD, PhD  ·  43 38811067  ·  paolo.meani@mumc.nl

Roberto Lorusso, MD,PhD  ·  43 38811067  ·  roberto.lorussobs@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Maastricht UMCMaastricht, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06766006